NewsWise: Study indicates COVID-19 boosters among vaccinated individuals significantly reduce hospitalization rates, add protection

NewsWise: Study indicates COVID-19 boosters among vaccinated individuals significantly reduce hospitalization rates, add protection. “Researchers found that boosters add about 70% extra protection, which lasts for 4-5 months, and concluded that booster vaccination is associated with significantly decreased odds of hospitalization for COVID-19 among fully vaccinated individuals. Odds of decreased hospitalization varied based on time since booster administration.”

New York Times: Fall Vaccination Campaign Will Bring New Shots, Worse Access

New York Times: Fall Vaccination Campaign Will Bring New Shots, Worse Access. “At the very moment a better coronavirus vaccine is expected to finally become available, America’s vaccination program is feeling the effects of a long period of retreat. Local programs to bring shots to the places where Americans gather and the institutions they trust have folded, a consequence in some cases of congressional resistance to more pandemic response spending.”

CDC: CDC Recommends Additional Boosters for Certain Individuals

CDC: CDC Recommends Additional Boosters for Certain Individuals. “Following FDA’s regulatory actionexternal icon today, CDC is updating its recommendations to allow certain immunocompromised individuals and people over the age of 50 who received an initial booster dose at least 4 months ago to be eligible for another mRNA booster to increase their protection against severe disease from COVID-19. Separately and in addition, based on newly published data, adults who received a primary vaccine and booster dose of Johnson & Johnson’s Janssen COVID-19 vaccine at least 4 months ago may now receive a second booster dose using an mRNA COVID-19 vaccine.”

CNN: Moderna seeks FDA authorization for second Covid-19 booster shot for all adults

CNN: Moderna seeks FDA authorization for second Covid-19 booster shot for all adults. “Moderna announced Thursday that it’s asked the US Food and Drug Administration for authorization for a second Covid-19 booster shot for everyone 18 and older. Moderna is seeking an amendment of the FDA’s emergency use authorization for its Covid-19 vaccine to allow a fourth vaccine dose for any adults who’ve gotten an initial booster of any of the authorized or approved vaccines.”

Jerusalem Post: Fourth vaccine offers little protection against COVID-19 – study

Jerusalem Post: Fourth vaccine offers little protection against COVID-19 – study. “The study, published by The New England Journal of Medicine, examines the efficacy of the fourth coronavirus vaccine from Pfizer and Moderna. The interim results released show that the vaccine offers little to no protection against the virus when compared to young and healthy individuals vaccinated with three doses. However, the vaccine did prove to provide moderate protection against symptomatic infection among young and healthy individuals in comparison to those inoculated three times.”

Associated Press: WHO says COVID boosters needed, reversing previous call

Associated Press: WHO says COVID boosters needed, reversing previous call. “An expert group convened by the World Health Organization said Tuesday it ‘strongly supports urgent and broad access’ to booster doses of COVID-19 vaccine amid the global spread of omicron, capping a reversal of the U.N. agency’s repeated insistence last year that boosters weren’t necessary for healthy people and contributed to vaccine inequity.”

Washington Post: Coronavirus vaccine protection was much weaker against omicron, data shows

Washington Post: Coronavirus vaccine protection was much weaker against omicron, data shows. “While coronavirus shots still provided protection during the omicron wave, the shield of coverage they offered was weaker than during other surges, according to new data from the Centers for Disease Control and Prevention. The change resulted in much higher rates of infection, hospitalization and death for fully vaccinated adults and even for people who had received boosters.”

Washington Post: Lab study shows omicron-blocking antibodies persist four months after a Pfizer-BioNTech booster

Washington Post: Lab study shows omicron-blocking antibodies persist four months after a Pfizer-BioNTech booster. “Virus-fighting antibodies capable of blocking the omicron variant persist four months after a third shot of the Pfizer-BioNTech coronavirus vaccine, according to a new study. The study, which was published on a preprint server Saturday, gives a first hint about the durability of coronavirus vaccine protection, with a key line of immune defense remaining intact. The study has not yet been peer-reviewed and will need to be replicated and extended to a longer period.”

The Malaysian Reserve: Thailand Rolls Out Fourth Covid Shot in Popular Tourist Spots

The Malaysian Reserve: Thailand Rolls Out Fourth Covid Shot in Popular Tourist Spots. “Authorities are offering AstraZeneca and Pfizer vaccines in Bangkok, Phuket, Krabi and seven other provinces to those who have received their third dose at least three months ago, the health ministry said. The Southeast Asian nation has already administered more than 800,000 fourth doses, mostly to healthcare workers and those in high-risk groups, official data showed.”

New York Times: Booster shots are instrumental in protecting against Omicron, new C.D.C. data suggest.

New York Times: Booster shots are instrumental in protecting against Omicron, new C.D.C. data suggest.. “Booster shots of the Pfizer-BioNTech and Moderna vaccines aren’t just preventing infections with the highly contagious Omicron variant — they’re also keeping infected Americans from ending up in the hospital, according to data published on Friday by the Centers for Disease Control and Prevention.”